PTC Therapeutics, Inc.
PTCT· Nasdaq
Released Oct 29, 2019, after the close
10-Q filed Oct 30, 2019, 30 days after period end · 0001070081-19-000057
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $71.42M | $53.59M | $41.78M | $22.99M |
| Net Income | -$60.00M | -$50.97M | -$33.74M | -$35.17M |
| EPS Diluted |
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR
| -$1.06 |
| -$1.06 |
| -$0.82 |
| -$1.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.